May 16, 2016

Update on Tesamorelin Marketing Authorization Application in Brazil

Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced that its commercial partner, Sanofi, along with Theratechnologies, have decided to withdraw the marketing authorization application for the registration of the 2 mg/vial presentation of tesamorelin in Brazil.